Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-010454 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
13,750
Total Value
$456,157.53
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Exercise/Conversion | 4,125 | $22.86 | $94,297.50 | 216,648 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Sale | 2,481 | $64.88 | $160,967.28 | 214,167 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Sale | 1,420 | $65.83 | $93,478.60 | 212,747 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Sale | 1,299 | $66.85 | $86,838.15 | 211,448 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Sale | 100 | $67.88 | $6,788.00 | 211,348 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Sale | 200 | $68.94 | $13,788.00 | 211,148 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Feb 4, 2026 | Exercise/Conversion | 4,125 | $0.00 | $0.00 | 135,415 | Direct | โ | View Details |